Prognostic validity of the American joint committee on cancer staging classification for midgut neuroendocrine tumors

Journal of Clinical Oncology

Volumn 31, Issue 4, 2013, Pages 420-425

  Strosberg, Jonathan R ^a   Weber, Jill M ^a   Feldman, Max ^b   Coppola, Domenico ^a   Meredith, Kenneth ^a   Kvols, Larry K ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ALPHA INTERFERON; CHROMOGRANIN A; CYTOTOXIC AGENT; EVEROLIMUS; KI 67 ANTIGEN; PENTETREOTIDE; PENTETREOTIDE IN 111; SUNITINIB;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER GRADING; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SCINTISCANNING; CANCER STAGING; CANCER SURVIVAL; CARCINOID; CECUM TUMOR; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; HUMAN; JEJUNUM TUMOR; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS RESECTION; MITOSIS; NEUROENDOCRINE TUMOR; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TUMOR DIFFERENTIATION; URINE LEVEL; ADVISORY COMMITTEE; INTESTINE TUMOR; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; REPRODUCIBILITY; RISK ASSESSMENT; UNITED STATES;

ADULT; ADVISORY COMMITTEES; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INTESTINAL NEOPLASMS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM STAGING; NEUROENDOCRINE TUMORS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; UNITED STATES;

MLCS; MLOWN;

EID: 84874773590     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.44.5924     Document Type: Article

References (18)

1. Pearse AG: The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept. J Histochem Cytochem 17: 303-313, 1969
2. Klimstra DS, Modlin IR, Coppola D, et al: The pathologic classification of neuroendocrine tumors: A review of nomenclature, grading, and staging systems. Pancreas 39: 707-712, 2010
3. Williams ED, Sandler M: The classification of carcinoid tumours. Lancet 1: 238-239, 1963
4. Thorson A, Biorck G, Bjorkman G, et al: Malignant carcinoid of the small intestine with metastases to the liver, valvular disease of the right side of the heart (pulmonary stenosis and tricuspid regurgitation without septal defects), peripheral vasomotor symptoms, bronchoconstriction, and an unusual type of cyanosis: A clinical and pathologic syndrome. Am Heart J 47: 795-817, 1954
5. Kvols LK, Reubi JC: Metastatic carcinoid tumors and the malignant carcinoid syndrome. Acta Oncol 32: 197-201, 1993 (Pubitemid 23188536)
6. Yao JC, Hassan M, Phan A, et al: One hundred years after "carcinoid": Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26: 3063-3072, 2008
7. Maggard MA, O'Connell JB, Ko CY: Updated population-based review of carcinoid tumors. Ann Surg 240: 117-122, 2004 (Pubitemid 38808243)
8. World Health Organization Classification of Tumors: Tumours of the Digestive System. Lyon, France, International Agency for Research on Cancer, 2000
9. Rindi G, Klöppel G, Couvelard A, et al: TNM staging of midgut and hindgut (neuro) endocrine tumors: A consensus proposal including a grading system. Virchows Arch 451: 757-762, 2007 (Pubitemid 47497934)
10. Edge SB, Byrd DR, Compton CC, et al (eds): AJCC Cancer Staging Manual (ed 7). Chicago, IL, Springer, 2010, p. 184
11. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40: 373-383, 1987 (Pubitemid 17055592)
12. Shariff SZ, Cuerden MS, Jain AK, et al: The secret of immortal time bias in epidemiologic studies. J Am Soc Nephrol 19: 841-843, 2008
13. Jann H, Roll S, Couvelard A, et al: Neuroendocrine tumors of midgut and hindgut origin: Tumornode- metastasis classification determines clinical outcome. Cancer 117: 3332-3341, 2011
14. Panzuto F, Boninsegna L, Fazio N, et al: Metastatic and locally advanced pancreatic endocrine carcinomas: Analysis of factors associated with disease progression. J Clin Oncol 29:2372- 2377, 2011
15. Scarpa A, Mantovani W, Capelli P, et al: Pancreatic endocrine tumors: Improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients. Mod Pathol 23: 824-833, 2010
16. Pape UF, Rinke A, Horsch D, et al: Distinct cut off values of Ki-67 index for neuroendocrine tumor (NET)-grading predict long-term outcome in gastrointestinal NET. United European Gastroenterology Week, Stockholm, Sweden, October 22-26, 2011 (abstr OP086)
17. Pellikka PA, Tajik AJ, Khandheria BK, et al: Carcinoid heart disease: Clinical and echocardiographic spectrum in 74 patients. Circulation 87: 1188-1196, 1993 (Pubitemid 23110391)
18. Zuetenhorst JM, Bonfrer JM, Korse CM, et al: Carcinoid heart disease: The role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-beta and fibroblast growth factor. Cancer 97: 1609-1615, 2003 (Pubitemid 36350703)